Published in J Biomed Nanotechnol on December 01, 2009
Targeted delivery of human VEGF gene via complexes of magnetic nanoparticle-adenoviral vectors enhanced cardiac regeneration. PLoS One (2012) 0.90
Characterization of magnetic viral complexes for targeted delivery in oncology. Theranostics (2015) 0.79
Generation of Transgenic Porcine Fibroblast Cell Lines Using Nanomagnetic Gene Delivery Vectors. Mol Biotechnol (2016) 0.75
Toll-like receptor expression in human keratinocytes: nuclear factor kappaB controlled gene activation by Staphylococcus aureus is toll-like receptor 2 but not toll-like receptor 4 or platelet activating factor receptor dependent. J Invest Dermatol (2003) 1.69
Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat Protoc (2007) 1.60
Labelling of cells with quantum dots. Nanotechnology (2005) 1.57
A novel transfecting peptide comprising a tetrameric nuclear localization sequence. J Mol Med (Berl) (2003) 1.48
Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J Gene Med (2004) 1.48
Percutaneous endoscopic gastrostomy in children on peritoneal dialysis. Perit Dial Int (2006) 1.47
Prevalence of WT1 mutations in a large cohort of patients with steroid-resistant and steroid-sensitive nephrotic syndrome. Kidney Int (2004) 1.46
Oligomers of the arginine-rich motif of the HIV-1 TAT protein are capable of transferring plasmid DNA into cells. J Biol Chem (2003) 1.45
Intrauterine growth restriction leads to a dysregulation of Wilms' tumour supressor gene 1 (WT1) and to early podocyte alterations. Nephrol Dial Transplant (2012) 1.44
Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy. J Control Release (2009) 1.42
Changes in 11beta-hydroxysteroid dehydrogenase type 2 expression in a low-protein rat model of intrauterine growth restriction. Nephrol Dial Transplant (2010) 1.40
Magnetofection--a highly efficient tool for antisense oligonucleotide delivery in vitro and in vivo. Mol Ther (2003) 1.29
Magnetofection potentiates gene delivery to cultured endothelial cells. J Vasc Res (2003) 1.20
Nonviral vector loaded collagen sponges for sustained gene delivery in vitro and in vivo. J Gene Med (2002) 1.15
Gene delivery to respiratory epithelial cells by magnetofection. J Gene Med (2004) 1.06
Alginate as a chondrocyte-delivery substance in combination with a non-woven scaffold for cartilage tissue engineering. Biomaterials (2002) 1.02
Tissue engineering of autologous cartilage grafts in three-dimensional in vitro macroaggregate culture system. Tissue Eng (2005) 1.00
Direct magnetic tubular cell seeding: a novel approach for vascular tissue engineering. Cells Tissues Organs (2006) 0.99
siRNA delivery by magnetofection. Curr Opin Mol Ther (2008) 0.98
Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo. J Vasc Res (2007) 0.95
Application of novel solid lipid nanoparticle (SLN)-gene vector formulations based on a dimeric HIV-1 TAT-peptide in vitro and in vivo. Pharm Res (2004) 0.94
Aerosolized nanogram quantities of plasmid DNA mediate highly efficient gene delivery to mouse airway epithelium. Mol Ther (2005) 0.94
Successful withdrawal of steroids in pediatric renal transplant recipients receiving cyclosporine A and mycophenolate mofetil treatment: results after four years. Transplantation (2004) 0.92
Recent advances in magnetofection and its potential to deliver siRNAs in vitro. Methods Mol Biol (2009) 0.92
Effects of low frequency electromagnetic fields on the chondrogenic differentiation of human mesenchymal stem cells. Bioelectromagnetics (2010) 0.92
Monomolecular assembly of siRNA and poly(ethylene glycol)-peptide copolymers. Biomacromolecules (2008) 0.91
Inhibition of TGF-β signaling and decreased apoptosis in IUGR-associated lung disease in rats. PLoS One (2011) 0.91
The implications of fetal programming of glomerular number and renal function. J Mol Med (Berl) (2009) 0.91
MRI of coronary wall remodeling in a swine model of coronary injury using an elastin-binding contrast agent. Circ Cardiovasc Imaging (2011) 0.91
Therapeutic vaccination with an interleukin-2-interferon-gamma-secreting allogeneic tumor vaccine in patients with progressive castration-resistant prostate cancer: a phase I/II trial. Hum Gene Ther (2009) 0.90
A fibrin glue composition as carrier for nucleic acid vectors. Pharm Res (2008) 0.90
Mannose receptor-mediated gene delivery into antigen presenting dendritic cells. Somat Cell Mol Genet (2002) 0.90
Genuine DNA/polyethylenimine (PEI) complexes improve transfection properties and cell survival. J Drug Target (2004) 0.89
Neoadjuvant gene delivery of feline granulocyte-macrophage colony-stimulating factor using magnetofection for the treatment of feline fibrosarcomas: a phase I trial. J Gene Med (2008) 0.87
Gene silencing mediated by magnetic lipospheres tagged with small interfering RNA. Nano Lett (2010) 0.87
Primary focal segmental glomerulosclerosis--long-term outcome after pediatric renal transplantation. Pediatr Transplant (2005) 0.86
Boosting oncolytic adenovirus potency with magnetic nanoparticles and magnetic force. Mol Pharm (2010) 0.85
Fetal programming of renal function. Pediatr Nephrol (2011) 0.85
Effects of nanoparticle coatings on the activity of oncolytic adenovirus-magnetic nanoparticle complexes. Biomaterials (2011) 0.85
Flap prefabrication and prelamination with tissue-engineered cartilage. J Reconstr Microsurg (2004) 0.85
Alpha-secretase inhibition reduces human glioblastoma stem cell growth in vitro and in vivo by inhibiting Notch. Neuro Oncol (2012) 0.84
Silica-iron oxide magnetic nanoparticles modified for gene delivery: a search for optimum and quantitative criteria. Pharm Res (2012) 0.84
Magnetofection: the use of magnetic nanoparticles for nucleic acid delivery. Cold Spring Harb Protoc (2009) 0.83
Magselectofection: an integrated method of nanomagnetic separation and genetic modification of target cells. Blood (2011) 0.83
In vivo analysis of retroviral gene transfer to chondrocytes within collagen scaffolds for the treatment of osteochondral defects. Biomaterials (2007) 0.83
Early and late postnatal myocardial and vascular changes in a protein restriction rat model of intrauterine growth restriction. PLoS One (2011) 0.83
Fetal programming of gene expression in growth-restricted rats depends on the cause of low birth weight. Endocrinology (2011) 0.83
Hydrochlorothiazide in CLDN16 mutation. Nephrol Dial Transplant (2006) 0.83
Low nephron number--a new cardiovascular risk factor in children? Pediatr Nephrol (2004) 0.83
Pediatric renal transplantation with mycophenolate mofetil-based immunosuppression without induction: results after three years. Transplantation (2003) 0.83
Magnetic resonance imaging: utility as a molecular imaging modality. Curr Top Dev Biol (2005) 0.82
The influence of the stable expression of BMP2 in fibrin clots on the remodelling and repair of osteochondral defects. Biomaterials (2009) 0.81
A strategy to establish a gene-activated matrix on titanium using gene vectors protected in a polylactide coating. Biomaterials (2011) 0.81
A self-normalization reconstruction technique for PET scans using the positron emission data. IEEE Trans Med Imaging (2012) 0.81
Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery. Pediatrics (2006) 0.80
Immunostimulation of bronchoalveolar lavage cells from recurrent airway obstruction-affected horses by different CpG-classes bound to gelatin nanoparticles. Vet Immunol Immunopathol (2011) 0.80
Non-viral VEGF(165) gene therapy--magnetofection of acoustically active magnetic lipospheres ('magnetobubbles') increases tissue survival in an oversized skin flap model. J Cell Mol Med (2008) 0.80
Nanomagnetic activation as a way to control the efficacy of nucleic acid delivery. Pharm Res (2014) 0.80
Nanomedicine: Silence the target. Nat Nanotechnol (2009) 0.79
Aerosol gene delivery to the murine lung is mouse strain dependent. J Mol Med (Berl) (2006) 0.79
Induction and coexpression of latent transforming growth factor beta-binding protein-1 and fibrillin-1 in experimental glomerulonephritis. Nephron Exp Nephrol (2005) 0.79
Five-year outcome in pediatric patients with mycophenolate mofetil-based renal transplantation. Transplantation (2007) 0.79
Effects of statins on nitric oxide/cGMP signaling in human umbilical vein endothelial cells. Pharmacol Rep (2010) 0.79
Effect of ingestion order of the fat component of a solid meal on intragastric fat distribution and gastric emptying assessed by MRI. J Magn Reson Imaging (2005) 0.79
Bioactivation of dermal scaffolds with a non-viral copolymer-protected gene vector. Biomaterials (2010) 0.79
Targeted magnetic liposomes loaded with doxorubicin. Methods Mol Biol (2010) 0.78
Biophysical characterization of copolymer-protected gene vectors. Biomacromolecules (2010) 0.78
Early postnatal hyperalimentation impairs renal function via SOCS-3 mediated renal postreceptor leptin resistance. Endocrinology (2012) 0.78
Pharmacokinetics and immunodynamics of basiliximab in pediatric renal transplant recipients on mycophenolate mofetil comedication. Transplantation (2008) 0.78
A nebulized gelatin nanoparticle-based CpG formulation is effective in immunotherapy of allergic horses. Pharm Res (2012) 0.78
Liposomal magnetofection. Methods Mol Biol (2010) 0.78
Site directed vascular gene delivery in vivo by ultrasonic destruction of magnetic nanoparticle coated microbubbles. Nanomedicine (2012) 0.77
End-stage renal failure as manifestation of adolescent cystinosis. Eur J Pediatr (2004) 0.77
Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids. Transplantation (2008) 0.77
Magnetically guided lentiviral-mediated transduction of airway epithelial cells. J Gene Med (2010) 0.77
Effects of adrenomedullin on the glomerular adrenomedullin system in a rat model of anti-thy1 glomerulonephritis. Nephron Exp Nephrol (2010) 0.76
Stability analysis of chemically modified mRNA using micropattern-based single-cell arrays. Lab Chip (2015) 0.76
Developmental regulation of inflammatory cytokine-mediated Stat3 signaling: the missing link between intrauterine growth restriction and pulmonary dysfunction? J Mol Med (Berl) (2012) 0.76
Hypergonadotropic hypogonadism and renal failure due to WT1 mutation. Nephrol Dial Transplant (2006) 0.76
Magnetic and acoustically active microbubbles loaded with nucleic acids for gene delivery. Methods Mol Biol (2013) 0.76
Efficient and stable gene transfer of growth factors into chondrogenic cells and primary articular chondrocytes using a VSV.G pseudotyped retroviral vector. Biomaterials (2008) 0.76
Is tacrolimus for childhood steroid-dependent nephrotic syndrome better than ciclosporin A? Nephrol Dial Transplant (2006) 0.76
Magnetic nanoparticles for biomedical applications. Pharm Res (2012) 0.76
Continuous flow generation of magnetoliposomes in a low-cost portable microfluidic platform. Lab Chip (2014) 0.76
Optimizing adenoviral transduction of endothelial cells under flow conditions. Pharm Res (2011) 0.75
The characterisation of human respiratory epithelial cells cultured on resorbable scaffolds: first steps towards a tissue engineered tracheal replacement. Biomaterials (2002) 0.75
Mycophenolate mofetil introduction stabilizes and subsequent cyclosporine A reduction slightly improves kidney function in pediatric renal transplant patients: a retrospective analysis. Pediatr Transplant (2006) 0.75
Pediatric renal allograft transplantation does not normalize the increased cortisol/cortisone ratios of chronic renal failure. Eur J Endocrinol (2006) 0.75
[Intrauterine growth restriction and renal function--a long-term problem?]. Gynakol Geburtshilfliche Rundsch (2009) 0.75
Autosomal recessive polycystic kidney disease: improvement of renal function. Eur J Pediatr (2003) 0.75
Thyroid hormone (T3)-modification of polyethyleneglycol (PEG)-polyethyleneimine (PEI) graft copolymers for improved gene delivery to hepatocytes. Biomaterials (2006) 0.75
Altered leptin secretion in hyperinsulinemic mice under hypoxic conditions. Regul Pept (2008) 0.75
The use of non-viral gene vectors for bioactive poly-(D,L-lactide) implant surfaces in bone tissue engineering. Eur Cell Mater (2012) 0.75
Persistent changes within the intrinsic kidney-associated NPY system and tubular function by litter size reduction. Nephrol Dial Transplant (2011) 0.75
Engineering magnetic nanoparticles and formulations for gene delivery. J Control Release (2010) 0.75
Magnetic nanoparticle and magnetic field assisted siRNA delivery in vitro. Methods Mol Biol (2015) 0.75